Loading organizations...
Loading organizations...
Biotechnology company developing placental-derived drugs for osteoarthritis
Doron Therapeutics has raised $11.0M across 1 funding round.
Doron Therapeutics has raised $11.0M in total across 1 funding round.
Doron Therapeutics has raised $11.0M in total across 1 funding round.
Doron Therapeutics's investors include SPRIM Global Investments.
Doron Therapeutics has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series A in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 27, 2024 | $11.0M Series A | SPRIM Global Investments |